News

Cancer treatment often involves powerful drugs that can damage the nerves, resulting in chemotherapy-induced peripheral neuropathy (CIPN). Although any type of cancer treatment can cause neuropathy, ...
There may be a strategy that regulates inflammation responsible for causing nerve pain due to chemotherapy-induced side ...
Published in Brain, Behavior and Immunity—is the first to suggest that a tumor-driving gene known as AEG-1 actively regulates ...
Please provide your email address to receive an email when new articles are posted on . Vitamin D insufficiency before chemotherapy associated with higher risk for peripheral neuropathy.
Doctors call this condition chemotherapy-induced peripheral neuropathy (CIPN). Symptoms can be severe and may affect a person’s quality of life. A 2014 study of 90 people receiving chemotherapy ...
A University of Arizona Comprehensive Cancer Center researcher received a $2.4 million National Cancer Institute grant to ...
Q: I have peripheral neuropathy following chemotherapy. Is there anything I can do to alleviate my symptoms? A: Chemotherapy-induced peripheral neuropathy is a set of symptoms caused by damage to ...
The randomized clinical trial found that exercise training reduced the onset of chemotherapy-induced peripheral neuropathy (CIPN) by 50 to 70 percent, depending on the type of chemo used.
Dr. Sharon Gurm, BSc. ND, FABNO, Naturopathic Oncologist, Port Moody, BC discusses how a naturopathic oncologist can help treat chemotherapy-induced peripheral neuropathy. Trump says U.S. will ...
There are few precise measures of how many cancer patients deal with chemotherapy-induced peripheral neuropathy, or CIPN, but the scope of the problem is clearly enormous. Scottish researchers ...
Considering taking supplements to treat chemotherapy induced peripheral neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of chemotherapy induced ...
Preclinical data show prevention of both chemotherapy ... but also neuropathy induced by ADC payloads" said David Liberg, Chief Scientific Officer at Cantargia. Peripheral neuropathic pain ...